# Huntsman CORP (HUN)

Informational only - not investment advice.

CIK: 0001307954
SIC: 2800 Chemicals & Allied Products
SIC breadcrumb: [Manufacturing](/division/D/) > [Chemicals And Allied Products](/major-group/28/) > [SIC 2800 Chemicals & Allied Products](/industry/2800/)
Latest 10-K filed: 2026-02-18
SEC page: https://www.sec.gov/edgar/browse/?CIK=1307954
Filing source: https://www.sec.gov/Archives/edgar/data/1307954/000143774926004524/hun20251231_10k.htm

## At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-18 · accession 0001437749-26-004524 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001307954.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 5,683,000,000 USD | 2025 | verified |
| Net income | -284,000,000 USD | 2025 | verified |
| Assets | 7,015,000,000 USD | 2025 | verified |
| Free cash flow | 116,000,000 USD | 2025 | computed |
| Net margin | -5.00% | 2025 | computed |
| Operating margin | -2.31% | 2025 | computed |
| Revenue YoY | -5.85% | 2025 | computed |
| ROE | -10.33% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | HUN | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | -5.0% | -5.0% | 50 | 11 |
| Operating margin | -2.3% | 0.1% | 38 | 9 |
| Revenue growth | -5.8% | 0.4% | 20 | 11 |
| FCF margin | 2.0% | 3.7% | 30 | 11 |
| ROE | -10.3% | -10.3% | 50 | 11 |
| ROA | -4.0% | -4.0% | 50 | 11 |
| Liabilities / equity | 1.48 | 1.48 | 50 | 11 |
| Current ratio | 1.30 | 1.78 | 10 | 11 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 2800 Chemicals & Allied Products, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 5683000000 | USD | 2025 | 2026-02-18 |
| Net income | -284000000 | USD | 2025 | 2026-02-18 |
| Assets | 7015000000 | USD | 2025 | 2026-02-18 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-18. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001307954.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2011 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue |  |  | 7,518,000,000 | 6,845,000,000 | 7,604,000,000 | 6,797,000,000 | 5,421,000,000 | 7,670,000,000 | 8,023,000,000 | 6,111,000,000 | 6,036,000,000 | 5,683,000,000 |
| Net income |  |  | 326,000,000 | 636,000,000 | 337,000,000 | 562,000,000 | 1,034,000,000 | 1,045,000,000 | 460,000,000 | 101,000,000 | -189,000,000 | -284,000,000 |
| Operating income |  |  | 663,000,000 | 729,000,000 | 827,000,000 | 469,000,000 | 432,000,000 | 731,000,000 | 672,000,000 | 84,000,000 | -25,000,000 | -131,000,000 |
| Gross profit |  |  | 1,518,000,000 | 1,651,000,000 | 1,764,000,000 | 1,382,000,000 | 977,000,000 | 1,584,000,000 | 1,546,000,000 | 906,000,000 | 866,000,000 | 751,000,000 |
| Diluted EPS |  |  | 1.36 | 2.61 | 1.39 | 2.44 | 4.66 | 4.72 | 2.27 | 0.57 | -1.10 | -1.65 |
| Operating cash flow |  |  | 1,088,000,000 | 1,219,000,000 | 1,207,000,000 | 897,000,000 | 253,000,000 | 952,000,000 | 914,000,000 | 209,000,000 | 263,000,000 | 289,000,000 |
| Capital expenditures |  |  | 318,000,000 | 234,000,000 | 251,000,000 | 274,000,000 | 237,000,000 | 326,000,000 | 272,000,000 | 230,000,000 | 184,000,000 | 173,000,000 |
| Dividends paid |  |  | 120,000,000 | 120,000,000 | 156,000,000 | 150,000,000 | 144,000,000 | 159,000,000 | 171,000,000 | 169,000,000 | 174,000,000 | 146,000,000 |
| Share buybacks | 50,000,000 | 100,000,000 |  |  | 277,000,000 | 208,000,000 | 96,000,000 | 200,000,000 | 1,005,000,000 | 349,000,000 | 4,000,000 | 0.00 |
| Assets |  |  | 9,189,000,000 | 10,244,000,000 | 7,953,000,000 | 8,320,000,000 | 8,713,000,000 | 9,392,000,000 | 8,220,000,000 | 7,248,000,000 | 7,114,000,000 | 7,015,000,000 |
| Liabilities |  |  | 7,722,000,000 | 6,873,000,000 | 5,204,000,000 | 5,496,000,000 | 5,040,000,000 | 4,833,000,000 | 4,380,000,000 | 3,770,000,000 | 3,951,000,000 | 4,058,000,000 |
| Stockholders' equity |  |  | 1,287,000,000 | 2,620,000,000 | 2,520,000,000 | 2,687,000,000 | 3,519,000,000 | 4,378,000,000 | 3,624,000,000 | 3,251,000,000 | 2,959,000,000 | 2,750,000,000 |
| Cash and cash equivalents |  |  | 385,000,000 | 470,000,000 | 340,000,000 | 525,000,000 | 1,593,000,000 | 1,041,000,000 | 654,000,000 | 540,000,000 | 340,000,000 | 429,000,000 |
| Free cash flow |  |  | 770,000,000 | 985,000,000 | 956,000,000 | 623,000,000 | 16,000,000 | 626,000,000 | 642,000,000 | -21,000,000 | 79,000,000 | 116,000,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2011 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin |  |  | 4.34% | 9.29% | 4.43% | 8.27% | 19.07% | 13.62% | 5.73% | 1.65% | -3.13% | -5.00% |
| Operating margin |  |  | 8.82% | 10.65% | 10.88% | 6.90% | 7.97% | 9.53% | 8.38% | 1.37% | -0.41% | -2.31% |
| Return on equity |  |  | 25.33% | 24.27% | 13.37% | 20.92% | 29.38% | 23.87% | 12.69% | 3.11% | -6.39% | -10.33% |
| Return on assets |  |  | 3.55% | 6.21% | 4.24% | 6.75% | 11.87% | 11.13% | 5.60% | 1.39% | -2.66% | -4.05% |
| Liabilities / equity |  |  | 6.00 | 2.62 | 2.07 | 2.05 | 1.43 | 1.10 | 1.21 | 1.16 | 1.34 | 1.48 |
| Current ratio |  |  | 2.00 | 1.83 | 1.84 | 1.87 | 1.80 | 1.92 | 1.85 | 1.97 | 1.36 | 1.30 |

## As-reported value updates

20 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

Ledger: /company/HUN/revisions/


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-01. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001307954.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q2 | 2022-06-30 |  |  | 1.10 | reported discrete quarter |
| 2022-Q3 | 2022-09-30 |  |  | 0.50 | reported discrete quarter |
| 2022-Q4 | 2022-12-31 | 1,650,000,000 | -91,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2023-Q1 | 2023-03-31 | 1,606,000,000 | 153,000,000 | 0.83 | reported discrete quarter |
| 2023-Q2 | 2023-06-30 | 1,596,000,000 | 19,000,000 | 0.11 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 1,506,000,000 | 0.00 | 0.00 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 1,403,000,000 | -71,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 1,470,000,000 | -37,000,000 | -0.22 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 1,574,000,000 | 22,000,000 | 0.13 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 1,540,000,000 | -33,000,000 | -0.19 | reported discrete quarter |
| 2025-Q1 | 2025-03-31 | 1,410,000,000 | -5,000,000 | -0.03 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 1,458,000,000 | -158,000,000 | -0.92 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 1,460,000,000 | -25,000,000 | -0.14 | reported discrete quarter |
| 2026-Q1 | 2026-03-31 | 1,420,000,000 | -53,000,000 | -0.31 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from HUN's latest 10-K: [/company/HUN/business/](/company/HUN/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from HUN's latest 10-K: [/company/HUN/risk-factors/](/company/HUN/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1307954/000143774926025186/hun20260630_10q.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture.
Confidence: high
Filing date: 2026-07-31
Report date: 2026-06-30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 

​

Results of Operations 

​

For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations (dollars in millions, except per share amounts):

​

Huntsman Corporation 

[[GREPCENT_TABLE]]
[["","","Three months ended","","","","","","","Six months ended"],["","","June 30,","","","Percent","","","June 30,","","","Percent"],["","","2026","","","2025","","","change","","","2026","","","2025","","","change"],["Revenues","","$","1,663","","","$","1,458","","","","14","%","","$","3,083","","","$","2,868","","","","7","%"],["Cost of goods sold","","","1,418","","","","1,276","","","","11","%","","","2,655","","","","2,485","","","","7","%"],["Gross profit","","","245","","","","182","","","","35","%","","","428","","","","383","","","","12","%"],["Operating expenses:"],["Selling, general and administrative","","","183","","","","160","","","","14","%","","","346","","","","326","","","","6","%"],["Research and development","","","28","","","","33","","","","(15",")%","","","57","","","","65","","","","(12",")%"],["Restructuring, impairment and plant closing costs","","","9","","","","124","","","","(93",")%","","","15","","","","125","","","","(88",")%"],["Gain on sale of business, net","","","(22",")","","","\u2014","","","","NM","","","","(22",")","","","\u2014","","","","NM"],["Income associated with litigation matter, net","","","\u2014","","","","\u2014","","","","\u2014","","","","\u2014","","","","(33",")","","","(100",")%"],["Gain on acquisition of assets, net","","","\u2014","","","","\u2014","","","","\u2014","","","","\u2014","","","","(5",")","","","(100",")%"],["Other operating expense (income), net","","","10","","","","(15",")","","","NM","","","","11","","","","(17",")","","","NM"],["Total operating expenses","","","208","","","","302","","","","(31",")%","","","407","","","","461","","","","(12",")%"],["Operating income (loss)","","","37","","","","(120",")","","","NM","","","","21","","","","(78",")","","","NM"],["Interest expense, net","","","(23",")","","","(21",")","","","10","%","","","(44",")","","","(40",")","","","10","%"],["Equity in income (loss) of investment in unconsolidated affiliates","","","5","","","","(2",")","","","NM","","","","10","","","","(1",")","","","NM"],["Other income, net","","","7","","","","4","","","","75","%","","","10","","","","7","","","","43","%"],["Income (loss) from continuing operations before income taxes","","","26","","","","(139",")","","","NM","","","","(3",")","","","(112",")","","","(97",")%"],["Income tax expense","","","(17",")","","","(7",")","","","143","%","","","(28",")","","","(22",")","","","27","%"],["Income (loss) from continuing operations","","","9","","","","(146",")","","","NM","","","","(31",")","","","(134",")","","","(77",")%"],["(Loss) income from discontinued operations, net of tax","","","(2",")","","","1","","","","NM","","","","(3",")","","","\u2014","","","","NM"],["Net income (loss)","","","7","","","","(145",")","","","NM","","","","(34",")","","","(134",")","","","(75",")%"],["Reconciliation of net income (loss) to adjusted EBITDA(1):"],["Net income attributable to noncontrolling interests","","","(13",")","","","(13",")","","","\u2014","","","","(25",")","","","(29",")","","","(14",")%"],["Interest expense, net","","","23","","","","21","","","","10","%","","","44","","","","40","","","","10","%"],["Income tax expense from continuing operations","","","17","","","","7","","","","143","%","","","28","","","","22","","","","27","%"],["Income tax expense from discontinued operations","","","\u2014","","","","1","","","","(100",")%","","","\u2014","","","","1","","","","(100",")%"],["Depreciation and amortization","","","77","","","","72","","","","7","%","","","150","","","","141","","","","6","%"],["Other adjustments:"],["Business acquisition and integration gain and purchase accounting inventory adjustments, net","","","\u2014","","","","\u2014","","","","","","","","\u2014","","","","(5",")"],["EBITDA from discontinued operations","","","2","","","","(2",")","","","","","","","3","","","","(1",")"],["Certain legal and other settlements and related expenses (income), net(2)","","","7","","","","1","","","","","","","","11","","","","(32",")"],["Gain on sale of business/assets, net(3)","","","(22",")","","","\u2014","","","","","","","","(22",")","","","\u2014"],["Expenses associated with the proposed merger","","","5","","","","\u2014","","","","","","","","5","","","","\u2014"],["Loss on early extinguishment of debt","","","\u2014","","","","\u2014","","","","","","","","1","","","","\u2014"],["Amortization of pension and postretirement actuarial losses","","","7","","","","7","","","","","","","","14","","","","14"],["Restructuring, impairment and plant closing and transition costs(4)","","","10","","","","125","","","","","","","","18","","","","129"],["Adjusted EBITDA(1)","","$","120","","","$","74","","","","62","%","","$","193","","","$","146","","","","32","%"],["Net cash (used in) provided by operating activities from continuing operations","","","","","","","","","","","","","","$","(113",")","","$","21","","","","NM"],["Net cash used in investing activities","","","","","","","","","","","","","","","(15",")","","","(32",")","","","(53",")%"],["Net cash provided by financing activities","","","","","","","","","","","","","","","43","","","","69","","","","(38",")%"],["Capital expenditures","","","","","","","","","","","","","","","(68",")","","","(73",")","","","(7",")%"],["Amounts attributable to Huntsman Corporation:"],["Loss from continuing operations","","$","(4",")","","$","(159",")","","","","","","$","(56",")","","$","(163",")"],["(Loss) income from discontinued operations, net of tax","","","(2",")","","","1","","","","","","","","(3",")","","","\u2014"],["Net loss","","$","(6",")","","$","(158",")","","","","","","$","(59",")","","$","(163",")"]]
[[/GREPCENT_TABLE]]

37

Table of Contents

Huntsman International 

[[GREPCENT_TABLE]]
[["","","Three months ended","","","","","","","Six months ended"],["","","June 30,","","","Percent","","","June 30,","","","Percent"],["","","2026","","","2025","","","change","","","2026","","","2025","","","change"],["Revenues","","$","1,663","","","$","1,458","","","","14","%","","$","3,083","","","$","2,868","","","","7","%"],["Cost of goods sold","","","1,418","","","","1,276","","","","11","%","","","2,655","","","","2,485","","","","7","%"],["Gross profit","","","245","","","","182","","","","35","%","","","428","","","","383","","","","12","%"],["Operating expenses:"],["Selling, general and administrative","","","183","","","","160","","","","14","%","","","344","","","","324","","","","6","%"],["Research and development","","","28","","","","33","","","","(15",")%","","","57","","","","65","","","","(12",")%"],["Restructuring, impairment and plant closing costs","","","9","","","","124","","","","(93",")%","","","15","","","","125","","","","(88",")%"],["Gain on sale of business, net","","","(22",")","","","\u2014","","","","NM","","","","(22",")","","","\u2014","","","","NM"],["Income associated with litigation matter, net","","","\u2014","","","","\u2014","","","","\u2014","","","","\u2014","","","","(33",")","","","(100",")%"],["Gain on acquisition of assets, net","","","\u2014","","","","\u2014","","","","\u2014","","","","\u2014","","","","(5",")","","","(100",")%"],["Other operating expense (income), net","","","10","","","","(15",")","","","NM","","","","11","","","","(17",")","","","NM"],["Total operating expenses","","","208","","","","302","","","","(31",")%","","","405","","","","459","","","","(12",")%"],["Operating income (loss)","","","37","","","","(120",")","","","NM","","","","23","","","","(76",")","","","NM"],["Interest expense, net","","","(23",")","","","(21",")","","","10","%","","","(44",")","","","(40",")","","","10","%"],["Equity in income (loss) of investment in unconsolidated affiliates","","","5","","","","(2",")","","","NM","","","","10","","","","(1",")","","","NM"],["Other income, net","","","7","","","","4","","","","75","%","","","10","","","","7","","","","43","%"],["Income (loss) from continuing operations before income taxes","","","26","","","","(139",")","","","NM","","","","(1",")","","","(110",")","","","(99",")%"],["Income tax expense","","","(17",")","","","(5",")","","","240","%","","","(28",")","","","(22",")","","","27","%"],["Income (loss) from continuing operations","","","9","","","","(144",")","","","NM","","","","(29",")","","","(132",")","","","(78",")%"],["(Loss) income from discontinued operations, net of tax","","","(2",")","","","1","","","","NM","","","","(3",")","","","\u2014","","","","NM"],["Net income (loss)","","","7","","","","(143",")","","","NM","","","","(32",")","","","(132",")","","","(76",")%"],["Reconciliation of net income (loss) to adjusted EBITDA(1):"],["Net income attributable to noncontrolling interests","","","(13",")","","","(13",")","","","\u2014","","","","(25",")","","","(29",")","","","(14",")%"],["Interest expense, net","","","23","","","","21","","","","10","%","","","44","","","","40","","","","10","%"],["Income tax expense from continuing operations","","","17","","","","5","","","","240","%","","","28","","","","22","","","","27","%"],["Income tax expense from discontinued operations","","","\u2014","","","","1","","","","(100",")%","","","\u2014","","","","1","","","","(100",")%"],["Depreciation and amortization","","","77","","","","72","","","","7","%","","","150","","","","141","","","","6","%"],["Other adjustments:"],["Business acquisition and integration gain and purchase accounting inventory adjustments, net","","","\u2014","","","","\u2014","","","","","","","","\u2014","","","","(5",")"],["EBITDA from discontinued operations","","","2","","","","(2",")","","","","","","","3","","","","(1",")"],["Certain legal and other settlements and related expenses (income), net(2)","","","7","","","","1","","","","","","","","11","","","","(32",")"],["Gain on sale of business/assets, net(3)","","","(22",")","","","\u2014","","","","","","","","(22",")","","","\u2014"],["Expenses associated with the proposed merger","","","5","","","","\u2014","","","","","","","","5","","","","\u2014"],["Loss on early extinguishment of debt","","","\u2014","","","","\u2014","","","","","","","","1","","","","\u2014"],["Amortization of pension and postretirement actuarial losses","","","7","","","","7","","","","","","","","14","","","","14"],["Restructuring, impairment and plant closing and transition costs(4)","","","10","","","","125","","","","","","","","18","","","","129"],["Adjusted EBITDA(1)","","$","120","","","$","74","","","","62","%","","$","195","","","$","148","","","","32","%"],["Net cash (used in) provided by operating activities from continuing operations","","","","","","","","","","","","","","$","(112",")","","$","22","","","","NM"],["Net cash used in investing activities","","","","","","","","","","","","","","","(21",")","","","(37",")","","","(43",")%"],["Net cash provided by financing activities","","","","","","","","","","","","","","","48","","","","73","","","","(34",")%"],["Capital expenditures","","","","","","","","","","","","","","","(68",")","","","(73",")","","","(7",")%"],["Amounts attributable to Huntsman International:"],["Loss from continuing operations","","$","(4",")","","$","(157",")","","","","","","$","(54",")","","$","(161",")"],["(Loss) income from discontinued operations, net of tax","","","(2",")","","","1","","","","","","","","(3",")","","","\u2014"],["Net loss","","$","(6",")","","$","(156",")","","","","","","$","(57",")","","$","(161",")"]]
[[/GREPCENT_TABLE]]

38

Table of Contents

Huntsman Corporation

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1307954/000143774926004524/hun20251231_10k.htm
Complete FY 2025 MD&A: /company/HUN/mda/fy2025/

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary.
Confidence: high
Filing date: 2026-02-18
Report date: 2025-12-31

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ReSULTS OF OPERATIONS

As discussed in “Note 4. Discontinued Operations—Sale of Textile Effects Business” to our consolidated financial statements, the results from continuing operations primarily exclude the results of our Textile Effects Business for all periods presented. For each of our Company and Huntsman International, the following tables set forth our consolidated results of operations for the years ended December 31, 2025, 2024 and 2023 (in millions, except per share amounts).

Huntsman Corporation

[[GREPCENT_TABLE]]
[["","","December 31,","","","Percent change"],["","","2025","","","2024","","","2023","","","2025 vs 2024","","2024 vs 2023"],["Revenues","","$","5,683","","","$","6,036","","","$","6,111","","","","(6",")%","","","(1",")%"],["Cost of goods sold","","","4,932","","","","5,170","","","","5,205","","","","(5",")%","","","(1",")%"],["Gross profit","","","751","","","","866","","","","906","","","","(13",")%","","","(4",")%"],["Operating expenses:"],["Selling, general and administrative","","","670","","","","671","","","","689","","","","\u2014","","","","(3",")%"],["Research and development","","","120","","","","121","","","","115","","","","(1",")%","","","5","%"],["Restructuring, impairment and plant closing costs","","","148","","","","39","","","","18","","","","279","%","","","117","%"],["Income associated with litigation matter, net","","","(33",")","","","\u2014","","","","\u2014","","","","NM","","","","NM"],["Gain on acquisition of assets, net","","","(5",")","","","(51",")","","","\u2014","","","","(90",")%","","","NM"],["Prepaid asset write-off","","","\u2014","","","","71","","","","\u2014","","","","(100",")%","","","NM"],["Loss on dissolution of subsidiaries","","","\u2014","","","","39","","","","\u2014","","","","(100",")%","","","NM"],["Other operating (income) expense, net","","","(18",")","","","1","","","","\u2014","","","","NM","","","","NM"],["Total operating expenses","","","882","","","","891","","","","822","","","","(1",")%","","","8","%"],["Operating (loss) income","","","(131",")","","","(25",")","","","84","","","","424","%","","","NM"],["Interest expense, net","","","(79",")","","","(79",")","","","(65",")","","","\u2014","","","","22","%"],["Equity in income of investment in unconsolidated affiliates","","","4","","","","44","","","","83","","","","(91",")%","","","(47",")%"],["Other income (expense), net","","","14","","","","21","","","","(3",")","","","(33",")%","","","NM"],["(Loss) income from continuing operations before income taxes","","","(192",")","","","(39",")","","","99","","","","392","%","","","NM"],["Income tax expense","","","(26",")","","","(61",")","","","(64",")","","","(57",")%","","","(5",")%"],["(Loss) income from continuing operations","","","(218",")","","","(100",")","","","35","","","","118","%","","","NM"],["(Loss) income from discontinued operations, net of tax","","","(9",")","","","(27",")","","","118","","","","(67",")%","","","NM"],["Net (loss) income","","","(227",")","","","(127",")","","","153","","","","79","%","","","NM"],["Reconciliation of net (loss) income to adjusted EBITDA(1):"],["Net income attributable to noncontrolling interests","","","(57",")","","","(62",")","","","(52",")","","","(8",")%","","","19","%"],["Interest expense, net from continuing operations","","","79","","","","79","","","","65","","","","\u2014","","","","22","%"],["Income tax expense from continuing operations","","","26","","","","61","","","","64","","","","(57",")%","","","(5",")%"],["Income tax (benefit) expense from discontinued operations","","","\u2014","","","","(11",")","","","17","","","","(100",")%","","","NM"],["Depreciation and amortization of continuing operations","","","287","","","","289","","","","278","","","","(1",")%","","","4","%"],["Other adjustments:"],["Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net","","","(4",")","","","21","","","","4"],["EBITDA from discontinued operations(2)","","","9","","","","38","","","","(135",")"],["Fair value adjustments to Venator investment, net and other tax matter adjustments","","","\u2014","","","","(12",")","","","5"],["Certain legal and other settlements and related (income) expenses, net(3)","","","(30",")","","","13","","","","6"],["Loss on sale of business/assets","","","5","","","","1","","","","\u2014"],["Loss on dissolution of subsidiaries(4)","","","\u2014","","","","39","","","","\u2014"],["Certain nonrecurring information technology project implementation costs","","","\u2014","","","","\u2014","","","","5"],["Amortization of pension and postretirement actuarial losses","","","34","","","","39","","","","37"],["Restructuring, impairment and plant closing and transition costs(5)","","","153","","","","46","","","","25"],["Adjusted EBITDA(1)","","$","275","","","$","414","","","$","472","","","","(34",")%","","","(12",")%"],["Net cash provided by operating activities from continuing operations","","$","298","","","$","285","","","$","251","","","","5","%","","","14","%"],["Net cash (used in) provided by investing activities from continuing operations","","","(132",")","","","(126",")","","","309","","","","5","%","","","NM"],["Net cash used in financing activities","","","(76",")","","","(326",")","","","(620",")","","","(77",")%","","","(47",")%"],["Capital expenditures from continuing operations","","","(173",")","","","(184",")","","","(230",")","","","(6",")%","","","(20",")%"],["Amounts attributable to Huntsman Corporation:"],["Loss from continuing operations","","$","(275",")","","$","(162",")","","$","(17",")"],["(Loss) income from discontinued operations, net of tax","","","(9",")","","","(27",")","","","118"],["Net (loss) income","","$","(284",")","","$","(189",")","","$","101"]]
[[/GREPCENT_TABLE]]

26

Table of Contents

Huntsman International

[[GREPCENT_TABLE]]
[["","","December 31,","","","Percent change"],["","","2025","","","2024","","","2023","","","2025 vs 2024","","2024 vs 2023"],["Revenues","","$","5,683","","","$","6,036","","","$","6,111","","","","(6",")%","","","(1",")%"],["Cost of goods sold","","","4,932","","","","5,170","","","","5,205","","","","(5",")%","","","(1",")%"],["Gross profit","","","751","","","","866","","","","906","","","","(13",")%","","","(4",")%"],["Operating expenses:"],["Selling, general and administrative","","","667","","","","668","","","","686","","","","\u2014","","","","(3",")%"],["Research and development","","","120","","","","121","","","","115","","","","(1",")%","","","5","%"],["Restructuring, impairment and plant closing costs","","","148","","","","39","","","","18","","","","279","%","","","117","%"],["Income associated with litigation matter, net","","","(33",")","","","\u2014","","","","\u2014","","","","NM","","","","NM"],["Gain on acquisition of assets, net","","","(5",")","","","(51",")","","","\u2014","","","","(90",")%","","","NM"],["Prepaid asset write-off","","","\u2014","","","","71","","","","\u2014","","","","(100",")%","","","NM"],["Loss on dissolution of subsidiaries","","","\u2014","","","","39","","","","\u2014","","","","(100",")%","","","NM"],["Other operating (income) expense, net","","","(18",")","","","1","","","","\u2014","","","","NM","","","","NM"],["Total operating expenses","","","879","","","","888","","","","819","","","","(1",")%","","","8","%"],["Operating (loss) income","","","(128",")","","","(22",")","","","87","","","","482","%","","","NM"],["Interest expense, net","","","(79",")","","","(79",")","","","(65",")","","","\u2014","","","","22","%"],["Equity in income of investment in unconsolidated affiliates","","","4","","","","44","","","","83","","","","(91",")%","","","(47",")%"],["Other income (expense), net","","","14","","","","21","","","","(3",")","","","(33",")%","","","NM"],["(Loss) income from continuing operations before income taxes","","","(189",")","","","(36",")","","","102","","","","425","%","","","NM"],["Income tax expense","","","(27",")","","","(62",")","","","(65",")","","","(56",")%","","","(5",")%"],["(Loss) income from continuing operations","","","(216",")","","","(98",")","","","37","","","","120","%","","","NM"],["(Loss) income from discontinued operations, net of tax","","","(9",")","","","(27",")","","","118","","","","(67",")%","","","NM"],["Net (loss) income","","","(225",")","","","(125",")","","","155","","","","80","%","","","NM"],["Reconciliation of net (loss) income to adjusted EBITDA(1):"],["Net income attributable to noncontrolling interests","","","(57",")","","","(62",")","","","(52",")","","","(8",")%","","","19","%"],["Interest expense, net from continuing operations","","","79","","","","79","","","","65","","","","\u2014","","","","22","%"],["Income tax expense from continuing operations","","","27","","","","62","","","","65","","","","(56",")%","","","(5",")%"],["Income tax (benefit) expense from discontinued operations","","","\u2014","","","","(11",")","","","17","","","","(100",")%","","","NM"],["Depreciation and amortization of continuing operations","","","287","","","","289","","","","278","","","","(1",")%","","","4","%"],["Other adjustments:"],["Business acquisition and integration (gain) expenses and purchase accounting inventory adjustments, net","","","(4",")","","","21","","","","4"],["EBITDA from discontinued operations(2)","","","9","","","","38","","","","(135",")"],["Fair value adjustments to Venator investment, net and other tax matter adjustments","","","\u2014","","","","(12",")","","","5"],["Certain legal and other settlements and related (income) expenses, net(3)","","","(30",")","","","13","","","","6"],["Loss on sale of business/assets","","","5","","","","1","","","","\u2014"],["Loss on dissolution of subsidiaries(4)","","","\u2014","","","","39","","","","\u2014"],["Certain nonrecurring information technology project implementation costs","","","\u2014","","","","\u2014","","","","5"],["Amortization of pension and postretirement actuarial losses","","","34","","","","39","","","","37"],["Restructuring, impairment and plant closing and transition costs(5)","","","153","","","","46","","","","25"],["Adjusted EBITDA(1)","","$","278","","","$","417","","","$","475","","","","(33",")%","","","(12",")%"],["Net cash provided by operating activities from continuing operations","","$","299","","","$","285","","","$","253","","","","5","%","","","13","%"],["Net cash used in investing activities from continuing operations","","","(137",")","","","(138",")","","","(42",")","","","\u2014","","","","229","%"],["Net cash used in financing activities","","","(72",")","","","(314",")","","","(271",")","","","(77",")%","","","16","%"],["Capital expenditures from continuing operations","","","(173",")","","","(184",")","","","(230",")","","","(6",")%","","","(20",")%"],["Amounts attributable to Huntsman International:"],["Loss from continuing operations","","$","(273",")","","$","(160",")","","$","(15",")"],["(Loss) income from discontinued operations, net of tax","","","(9",")","","","(27",")","","","118"],["Net (loss) income","","$","(282",")","","$","(187",")","","$","103"]]
[[/GREPCENT_TABLE]]

27

Table of Contents

Huntsman Corporation

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/HUN/mda/fy2025/
All MD&A years: /company/HUN/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/HUN/mda/fy2024/): filed 2025-02-18; accession 0001437749-25-004205 (https://www.sec.gov/Archives/edgar/data/1307954/000143774925004205/hun20241231_10k.htm)
- [FY 2023 MD&A](/company/HUN/mda/fy2023/): filed 2024-02-22; accession 0001437749-24-005185 (https://www.sec.gov/Archives/edgar/data/1307954/000143774924005185/hun20231231_10k.htm)
- [FY 2022 MD&A](/company/HUN/mda/fy2022/): filed 2023-02-21; accession 0001437749-23-003950 (https://www.sec.gov/Archives/edgar/data/1307954/000143774923003950/hun20221231_10k.htm)
- [FY 2021 MD&A](/company/HUN/mda/fy2021/): filed 2022-02-15; accession 0001437749-22-003430 (https://www.sec.gov/Archives/edgar/data/1307954/000143774922003430/hun20211231_10k.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 2800 Chemicals & Allied Products) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm

Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/HUN.md · JSON record: /company/HUN.json · verified financials: /company/HUN/financials.json / /company/HUN/financials.csv · machine TOC for the whole site: /llms.txt